SUMMARY ANSWER: Platelets impair NK cell reactivity and function in endometriosis through multiple mechanisms.
Introduction
Characterized by lesions of endometrial-like tissue outside of the uterine cavity, endometriosis is an estrogen-dependent and inflammatory disease associated with pelvic pain and infertility (Johnson et al., 2013) . Despite extensive research, our understanding of the pathogenesis and pathophysiology of endometriosis is still fragmentary (Johnson et al., 2013) . It has long been suspected that a deficient immune system may be involved (Dmowski et al., 1981; 1989) .
As a component of innate immunity, natural killer (NK) cells are a subset of lymphocytes that provide the first-line defense against infected or transformed cells by release of cytotoxic granules and cytokine secretion without prior sensitization (Smyth et al., 2002; Caligiuri, 2008) . The function of NK cells is tightly regulated by a combination of functionally opposing cell surface receptors, inhibitory killer immunoglobulin-like receptors (KIRs) that bind major histocompatibility complex class I (MHC-I) molecules and protect 'self' and activating receptors that bind ligands on transformed cells and eliminate them (Lanier, 2003) . Cells with low or absent expression of MHC-I ('missing self'), such as tumor cells, will be identified as 'non-self' and targeted by NK cells while harmful or transformed cells expressing stressinduced activating ligands ('induced self' or 'altered self') will turn on and energize NK cell activating receptors, resulting in lysis by NK cells (Vivier et al., 2008; Orr and Lanier, 2010) . Both activating and inhibitory receptors can transduce, respectively, positive ('missing self' or 'altered self') or negative ('self') signals to regulate NK cell cytotoxicity and cytokine release that kills the cells deemed to be harmful (Cheent and Khakoo, 2009) . Two checkpoints control NK cell activation: the first checkpoint is represented by ligands for activating receptors that are expressed de novo by potentially dangerous cells while the second involves the MHC-I-specific KIRs that sense the loss of 'self' labels on these cells (Moretta et al., 2002) .
In endometriosis, the impaired NK cell cytotoxicity as well as decreased NK cells in peritoneal fluid (PF) and sera were noted in early 1990s (Oosterlynck et al., 1991 (Oosterlynck et al., , 1992 Tanaka et al., 1992; Garzetti et al., 1993; Kikuchi et al., 1993; Somigliana et al., 1996a, b) . Peritoneal fluid (Oosterlynck et al., 1993) and sera (Kanzaki et al., 1992) from patients with endometriosis as well as endometriosis-secreted factors (Hirata et al., 1994; Somigliana et al., 1996a, b) have been reported to reduce NK cell cytotoxicity. In addition, the increased expression of some KIRs, such as KIR, two Ig domains and long cytoplasmic tail 1 (KIR2DL1) (Maeda et al., 2002 (Maeda et al., , 2004 Matsuoka et al., 2005) , KIR3DL1 (Wu et al., 2000) and NK Group 2, Member A (NKG2A) (Galandrini et al., 2008) , has also been reported. Moreover, reduced expression of activating receptors, such as NK cell p46-related protein (NKp46) (Funamizu et al., 2014) , has been reported. Consistently, HLA-G, a non-classical MHC-I molecule and a ligand for KIR2DL4, has been reported to be expressed in endometriotic cells (Barrier et al., 2006; Wang et al., 2008) , and the role of MHC-I in the impairment of NK cell functions in endometriosis has long been suspected (Semino et al., 1995) . The eutopic endometrium of women with endometriosis also expresses higher MHC-I than that of healthy women (VernetTomas Mdel et al., 2006) . Thus, the aberrant expression of NK cell KIRs and activating receptors may be responsible for decreased NK cell cytotoxicity in women with endometriosis. Conceivably, the reduced cytotoxicity would diminish the removal of ectopic endometrial tissues, allowing their survival, implantation and proliferation. As such, impaired NK cell function may play an essential role in the pathogenesis of the disease (Lebovic et al., 2001) . Despite all these findings, however, the molecular mechanisms underlying the reported dysregulated NK cell surface receptors are poorly understood, and it is unclear what the factors are in the peritoneal or sera of women with endometriosis that impair the NK cell cytotoxicity (Thiruchelvam et al., 2015; Jeung et al., 2016) . It is even unclear whether depletion of NK cells would facilitate the development of endometriosis.
We have recently shown that platelets play important roles in the development of endometriosis Guo et al., 2015; Zhang et al., 2015 Zhang et al., , 2016a and found that endometriotic stromal cells release platelet-activating molecules . We have also reported that platelet-derived transforming growth factor-β1 (TGF-β1) suppresses the expression of NKG2D on NK cells, resulting in reduced cytotoxicity in women with endometriosis, but neutralization of TGF-β1 reverses the reduction (Guo et al., 2016c) . However, it is unclear whether the three entities, i.e. endometriotic cells, NK cells and platelets, engage in any cross-talk, and, if so, what the molecular mechanisms and the consequences of the cross-talk between platelets and NK cells and between platelets and endometriotic cells might be. Given the well-documented roles of platelets in modulation of NK cell function in tumorigenesis and metastasis (Nieswandt et al., 1999; Palumbo et al., 2007; Kopp et al., 2009; Placke et al., 2012a,b,c) , it is likely that platelets may also modulate NK cell functions in the development of endometriosis.
We hypothesized that through interaction with either NK cells or the target cells, platelets and their secreted soluble factors impair NK cell cytotoxicity by regulating NK cell surface receptors, reducing interferon (IFN)-γ production and attenuation of NK cell degranulation. In addition, since activated platelets express large amount of MHC-I (Chapman et al., 2012) , the close proximity of NK cells with endometriotic cells following adhesion and aggregation of platelets to ectopic implants may transfer MHC-I to endometriotic cells, conferring a 'pseudo-self' phenotype and thus subverting NK cell immunosurveillance. This study was undertaken to test these hypotheses.
Materials and Methods

Cells and reagents
An immortalized endometrial stromal cell line (ESC), established by Krikun et al. (2004) , was kindly provided by Dr Asgi Fazleabas. Following Krikun et al., (2004) , cells were maintained in phenol red-free DMEM/F12 (Gibco, CA, USA) medium supplemented with 10% (v/v) fetal bovine serum (FBS) (Gibco Laboratories, Life Technologies, Grand island, NY, USA), 1 µl/ml sodium pyruvate (Gibco, 11360070) and 100 U/ml Pen/Strep/ Fungizone (Gibco), at 37°C with 5% CO 2 in air in a humidified incubator. A human endometriotic epithelial cell line (HEEC), 11Z, established by Dr Anna Strazinski-Powitz (Gaetje et al., 1997) , was kindly provided by Dr Jung-Hye Choi of Kyung Hee University, Seoul,Republic of Korea and cultured in RPMI 1640 medium (Gibco Laboratories) supplemented with 5% (v/v) FBS (Gibco Laboratories),100 IU/ml penicillin G, 100 mg/ml streptomycin and 2.5 mg/ml Amphotericin B (Hyclone, Utah, USA). Nonimmune (NI) IgG (C301, which is isotype-matched with R300) and rat anti-mouse GPIbα (CD42b) antibody (R300) were purchased from Emfret Analytics (Eibelstadt, Germany). The anti-ganglio-N-tetraosylceramide (GM) antibody was from Wako (Duesseldorf, Germany). Anti-mouse primary antibodies against TGF-β1, proliferating cell nuclear antigen (PCNA), vascular endothelial growth factor (VEGF), CD31 (for the measurement of microvessel density (MVD)), anti-human KIR2DL1-PerCP and vimentin antibodies were purchased from Abcam (Cambridge, MA, USA). The NK Cell Isolation Kit II was purchased from Miltenyi Biotech (Bergisch Gladbach, Germany). Anti-human CD56-FITC, NKp44-PE, KIR3DL1-APC and MHC-I (HLA-A, -B and -C)-PE antibodies were from Biolegend (San Diego, CA, USA). Anti-human CD3-PE, NKG2D-APC, NKp46-APC, CD61-APC and CD62P-FITC were purchased from eBioscience (San Diego, CA, USA). Anti-human pan-cytokeratin and MHC-I antibodies were obtained from Thermo Fisher Scientific (Waltham, MA, USA). Dylight 649 (red) and Dylight 488 (green) were purchased from EarthOx (San Francisco, CA, USA), and Alexa Fluor 555 (yellow) was purchased from Cell Signaling Technology (Boston, MA, USA). The IFN-γ ELISA kit was purchased from Abcam. A83-01, an inhibitor of TGF-β1 Type I receptor (Tojo et al., 2005) , was purchased TOCRIS (Missouri, MO, USA).
Animals and the mouse experiment protocol
Sixty-eight 8-week-old female Balb/C mice, 18-20 g in weight, were purchased from the SLAC Laboratory Animals (Shanghai, China) and used for this study. All mice were maintained under controlled conditions with a light/dark cycle of 12/12 h and had access to food and water ad libitum in the Animal Facility at Fudan University Shanghai College of Medicine. All experiments were performed following the guidelines of the National Research Council's Guide for the Care and Use of Laboratory Animals (Council, 1996) and approved by the institutional experimental animals review board of Shanghai OB/GYN Hospital, Fudan University.
Twenty mice were used for pilot studies of platelet depletion (PD) and NK cell depletion to ensure that the depletion scheduling and doses used in the mouse experiment protocol were correct. The procedures and results are detailed in Supplementary Information.
After 1 week of acclimatization, but 3 days before the induction of endometriosis (for more details on the procedures of endometriosis induction, see Supplementary Information), all mice, except 16 that were selected randomly as donors that contributed endometrial tissue fragments, were administrated the baseline hotplate test as reported previously and weighted (Lu et al., 2010) . The remaining 32 mice were randomly divided into four groups of equal sizes: (i) control group (NI); (ii) PD group; (iii) NK cell depletion group (ND) and (iv) concomitant platelet and NK cell depletion group (CD).
Designating Day 0 as the day when the endometriosis-inducing procedure was performed, the PD mice were injected i.v. with 1.5 μg/g bodyweight rat anti-mouse GPIbα (CD42b) antibody (R300) in 150 μl sterile phosphate buffer saline (PBS) to deplete platelets at Days −2, 3, and 8, i.e. every 5 days. The NI mice were injected i.v. with 1.5 μg/g bodyweight NI isotype-matched IgG (C301) also in 150 μl sterile PBS at the identical time points as the PD mice. The ND mice received an i.p. injection of 30 μg/g bodyweight anti-asialo-GM Ab in 150 μl sterile PBS to depletion NK cells at Days −3, 0, 3, 6 and 9, respectively, i.e. every 3 days. The CD mice received both i.p. injection of anti-asialo-GM antibody just like the ND group and also received i.v. injection of anti-platelet antibody just like the PD group. The choice of timing and dosage of injection was based on the manufactures' information sheets and our pilot experimentation. Before any procedure was performed, the hotplate test was administrated and the bodyweight was measured for all mice.
Twelve days after induction, the hotplate test was administrated again and the bodyweight was also measured for all mice. The abdominal cavity was opened up, and all lesions were excised, carefully weighed and then fixed for immunohistochemistry analysis (see below). The lesion dry weight was determined following Bacci et al., 2009 . The schema for the design of this protocol is shown in Supplementary Fig. S1 .
Histology and immunohistochemistry
For the mouse experiments, serial 4-μm sections of lesions were obtained from each formalin-fixed, paraffin-embedded tissue block, with the first resultant slide being stained for H&E to confirm pathologic diagnosis and the subsequent slides stained for TGF-β1, PCNA, VEGF and MVD. The primary antibodies used for the immunohistochemistry analysis, along with vendor names, catalog numbers and the concentrations, are listed in the Supplementary Table S1 . The procedures and quantification of immunohistochemistry are fully described in the Supplementary Information, along with the representative figures for positive and negative controls ( Supplementary Fig. S2 ).
Hematoxylin-eosin (H&E) staining and calculation of proportion of epithelium and stroma components in ectopic endometrium All lesion samples were evaluated by H&E staining using the H&E staining kit (Sun Biotec, Shanghai, China). Slides were dehydrated, mounted and observed under ×200 magnification using an Olympus microscope (Olympus, Tokyo, Japan) and the area of epithelium or stroma of lesions were calculated by the Image-Pro Plus 6.0 following Hull et al., 2012. Preparation of platelets and NK cells from peripheral blood samples Blood samples were donated by healthy male volunteers who gave written informed consent and denied taking any medications for at least 3 weeks prior to the donation, as described previously . Twenty milliliters of citrated blood was first centrifuged at 150g for 10 min, the supernatant platelet rich plasma (PRP) was then centrifuged at 300g for 5 min and the supernatant PRP was harvested again and then centrifuged at 1000g for 14 min following Merolla et al., 2012 . Finally, the depositing platelets were suspended in Dulbecco's Modified Eagle Media: Nutrient Mixture F-12 (DMEM/F12) culture medium with 10% (v/v) FBS, for further use, yielding~2 × 10 8 platelets from 20 ml of blood samples.
Activated platelets (PLT+THB) were obtained by adding 0.075 IU/ml thrombin (T8885, Sigma, St. Louis, MO, USA) into the platelets. Then platelet suspensions were stirred for 10 min at 200 g and subsequently centrifuged at 900g for 15 min. The supernatant was used as platelet releasate (PLT-RLS), and the precipitation was used as platelet pellet (PLT-PT) (Kopp et al., 2009) .
Human peripheral blood mononuclear cells (PBMCs) were derived from blood samples donated by healthy male volunteers. PBMCs were isolated by Ficoll-Hypaque density gradient centrifugation (STEMCELL Technologies, Vancouver, Canada), from which the NK cells were collected by the NK Cell Isolation Kit II. The purity of the freshly isolated NK cells was~90% as indicated by CD3 
Immunofluorescence
The cell culture procedure is described fully in the Supplementary Information. ESCs and HEECs were treated with PBS, platelets (PLT), thrombin (THB) alone or platelets activated by THB (PLT+THB) overnight, then washed with PBS twice and fixed with 4% formaldehyde. For blocking nonspecific binding sites, 5% (v/v) goat serum was used. The indicated primary antibodies were incubated overnight at 4°C. After washing with PBS thrice, appropriate secondary antibodies were added for 60 min at 37°C. After labeling, cells were mounted on slides using VECTASHIELD with DAPI (Vector Laboratories, Burlingame, CA, USA) and examined under a confocal laser scanning microscope (Leica TCS SP5 Confocal Microscope, Solms, Germany) at room temperature.
Cytotoxicity assay
NK cell cytotoxicity was determined using the standard lactate dehydrogenase (LDH) release assay (Broussas et al., 2013) . The concentration of LDH in the co-culture media was measured by LDH assay kit (Biovision, Milpitas, CA, USA). The percentage of lysis was calculated as: (experimental LDH release − spontaneous target cells LDH release − spontaneous effector cells LDH release)/(maximum LDH release − spontaneous target cells LDH release) × 100%, as reported previously (Broussas, Broyer and Goetsch, 2013) . 
Detection of apoptosis in NK cells
RNA isolation and real-time RT-PCR
Target cells (ESCs/HEECs) or NK cells were treated with PBS, PLT, PLT+THB, PLT-RLS, PLT-PT or thrombin overnight, then washed with PBS twice. The mRNA abundance of NKG2D, NKp44, NKp46, KIR2DL1 and KIR3DL1 on NK cells and of HLA-C, MICA and MICB on target cells were evaluated by real-time RT-PCR using SYBR Premix Ex Taq (Takara) using primers listed in Table I . These expression levels of these genes were determined using the ΔΔ -CT method with GAPDH as the housekeeping gene (Livak and Schmittgen, 2001 ).
The effect of suppressing TGF-β1 signaling on the expression of select NK cell surface receptors
To investigate the effect of suppressing TGF-β1 signaling on NK cell function, the expression of the select NK receptors and NK cytotoxicity were measured after NK cells were treated with the activated platelets or PLT-RLS with additional 10 μΜ A83-01 or vehicle at 37°C for 8 h, then NK cytotoxicity was measured as above. The gene expression levels of NKG2D, NKp44, NKp46, KIR2DL1 and KIR3DL1 were determined by real-time RT-PCR using the same method as described above. PBS twice and the percentage of NKG2D, NKp44, NKp46, KIR2DL1 and KIR3DL1 expression was measured on CD3 − CD56 + gated cells using
Fluorescence-activated cell sorting
FACS.
The target cells (ESCs or HEECs) were treated with platelets activated by 0.075 IU/ml thrombin for 30 min, then platelet alone, ESCs or HEESs alone and platelet treated target cells were incubated with CD61-APC, CD62P-FITC and MHC-I (HLA-A, -B, -C)-PE 30 min in dark at 4°C, respectively, then the cells and platelets were wash with cold PBS twice and the fluorescence intensity of CD61, CD62P and MHC-I were measured by FACS.
Degranulation assay
We performed degranulation assays using CD107a expression as surrogate marker for granule mobilization. NK cells were incubated with PBS, PLT, PLT + THB, PLT-RLS, PLT-PT or THB alone for 4 h, and then cocultured with ESCs/HEECs for additional 4 h. The CD107a expression on NK cells was determined by FACS.
ELISA
The quantification of IFN-γ was done using an ELISA kit (Abcam) following the manufacture's instruction. After NK cells co-cultured with platelets overnight, the co-culture media with target cells were collected, and centrifuged at 300g for 10 min, and then the IFN-γ concentration was measured using the kit. The assay was performed in triplicate. The detection limit of the IFN-γ kit was 5 pg/ml. The intra-assay coefficient of variation was 7.8%.
Statistical analysis
The comparison of distributions of continuous variables between or among two or more groups was made using the Wilcoxon's and Kruskal's test, respectively, and the paired Wilcoxon test was used when the before-after comparison was made for the same group of subjects. Pearson's or Spearman's rank correlation coefficient was used when evaluating correlations between two variables when both variables were continuous or when at least one variable was ordinal. To evaluate the effect of platelet and/or NK cell depletion and other factors on lesion size and immunoreactivity measurements, multiple linear regression models were used. For gene expression levels, the relative fold-change of gene expression was determined by normalizing to GAPDH and calculating the 2 −ΔΔCT (Livak and Schmittgen, 2001) . P values of <0.05 were considered statistically significant. All computations were made with R 3.3.1 (R Core Team, 2013) (www.r-project.org).
Results
Effect of NK and/or PD on ectopic endometrium
PD resulted in an average reduction in platelet count by 89%, 71%, 63% and 28%, respectively, on Days 1, 2, 3 and 4 from the basal platelet counts of 299 × 10 9 /l at Day 0 before anti-platelet antibody was administrated to the mice ( Supplementary Fig. S3 ). NK cell depletion resulted in an average reduction in NK cell count by 61%, 32% and 11%, respectively, on Days 1, 2 and 3 ( Supplementary Fig. S4 ). These results provided a justification for the injection scheduling that was used in this experiment. We found that PD significantly reduced but ND significantly increased the lesion weight (both P-values < 0.01; Fig. 1A ; Supplementary Fig. S5 ). Just as suspected, concomitant depletion of platelets and NK cells resulted in significantly increased lesion weight (P = 0.016; Fig. 1A ). In fact, a multiple linear regression analysis with bodyweight, PD status, NK cell depletion status and the interaction between PD and ND as covariables indicated that while PD reduces but ND increases the lesion weight (P < 0.001 and P < 0.01, respectively), concomitant platelet and NK cell depletion increases the lesion weight (P < 0.001, R 2 = 0.77). Of note, PD resulted in an average of 68% reduction in lesion weight, while ND and CD yielded an increase of average lesion weight by 67% and 69%, respectively (Fig. 1A) . As expected, there was no difference in hotplate latency prior to the induction of endometriosis as well as prior to any intervention (P > 0.05; Fig. 1B ). Twelve days after the induction procedure, however, there was a significant reduction in latency (P < 0.01, Fig. 1B) . A multiple linear regression analysis on the change in latency using baseline latency, bodyweight, lesion weight, PD status, NK cell depletion status and the interaction between PD and ND as covariables indicated that both the baseline latency and NK cell depletion were significantly associated with decrease in latency (both P-values < 0.001; R 2 = 0.58). PD also significantly reduced but ND significantly increased the stromal versus epithelial ratio in ectopic endometrium (both P-values < 0.001; Fig. 1C ), and joint depletion of platelets and NK cells resulted in significantly increased the ratio (P < 0.01; Fig. 1C ). In particular, the stroma-versus-epithelium ratio was positively correlated with the lesion weight (r = 0.72, P < 0.001, both variables were log-transformed; Fig. 1D ).
We further performed an immunohistochemistry analysis of PCNA (as a marker for proliferation), VEGF (angiogenesis), CD31 (for the MVD) and TGF-β1 (Fig. 2) . As expected, CD31 staining was seen mostly in vascular endothelial cells. PCNA staining was seen in cellular nuclei of both the stromal and glandular epithelial cells of the ectopic lesion. And VEGF staining was seen in vascular endothelial cells and mostly glandular epithelial cells of the ectopic lesion, while TGF-β1 was seen both the stromal and glandular epithelial cells of the ectopic lesion, especially in the glandular epithelial cells.
We found that, for all measurements, PD resulted in significant reduction while ND yielded an increase. While non-parametric statistical analysis indicated that for all measures there was no difference between groups NI and CD ( Fig. 2B-E) , multiple linear regression analyses, which were more efficient in using all data, indicated that, with the only exception for VEGF, concomitant PD and ND also increased immunoreactivity to PCNA and TGF-β1, and MVD ( Fig. 2B-E) .
Platelet coating causes enhanced MHC-I expression by ESC/HEEC
We co-incubated ESCs or HEEC with either PBS, freshly isolated platelets (PLT), platelets activated by thrombin (PLT + THB), or thrombin alone (THB) and then evaluated the interaction, if any, between the two by immunofluorescence analysis. We found that platelets, especially the activated ones, adhered to or surrounded the ESCs/ HEECs, effectively providing a physical shield (Fig. 3A and B) . None of ESCs/HEECs expressed integrin αIIb (CD41), nor did they express MHC-I but platelets, especially activated ones, expressed both ( Fig. 3A and B) . The coating by activated platelets resulted in ESCs/ HEEC displaying 'pseudo-expression' of CD41 and high-level MHC Class I (MHC-I) on the cell surface in all cases (Fig. 3A and B) . This indicated that ECS/HEEC cells coated with platelets resulted in substantial MHC-I 'pseudo-expression'.
We also measured the expression of CD61 (β 3 integrin), P-selectin (CD62P) and MHC-I (HLA-A, -B and -C) on platelets, ESCs/HEECs alone or ESCs/HEECs after co-incubation with activated platelets respectively using FACS. As expected, platelets displayed high levels of CD61 and MHC-I while ESCs and HEEC, in contrast, were negative for CD61 and had negligible levels of P-selectin and low level of MHC-I (Fig. 3C) . However, after co-incubation with platelets, platelets adhered onto the target cells (ESCs/HEECs) and resulted in the transfer of platelet marker expression to the target cells or the 'pseudoexpression' of CD61 as well as MHC-I on the cell surface (Fig. 3C) .
We also measured expression levels of HLA-C on target cells using real-time PCR. We found that ESCs/HEECs co-incubated with platelets and their releasate/pellets displayed significantly elevated HLA-C expression (Fig. 3D) . In addition, since platelet-derived soluble factors, such as MHC-I or TGF-β1, may be involved in modulating the NK cytotoxicity (Guo et al., 2016c) , we also evaluated the expression levels of HLA-C in ESCs/HEECs co-incubated with platelet releasate (PLT-RLS, which subsumes all platelet-derived soluble factors) as well as platelet pellets (PLT-PT, which resembles more a physical cloak that shields the target cells) and found that in both cases the HLA-C expression levels were significantly increased as compared with controls (Fig. 3D) .
Taken together, these data demonstrate that endometriotic stromal and epithelial cells are rapidly coated by platelets in vitro, resulting in expression of platelet markers and also MHC-I by endometriotic cells.
Co-incubation of endometriotic cells with platelets reduces the expression of NKG2D ligands MICA and MICB
Since the reduced NK cell cytotoxicity in endometriosis is attributable, at least in part, to the reduced NK cell activating receptor NKG2D (Guo et al., 2016c) , we wondered whether platelets have any effect on the expression of its ligands MICA and MICB in the target cells. We found that the expression levels of MICA/B in both endometriotic stromal and epithelial cells were significantly reduced after coincubation with PLT+THB and, in some cases, PLT, PLT-RLS and PLT-PT but not THB (Fig. 4A) . (microvessel density, CD31-labeled endothelial cells) and transforming growth factor-β1 (TGF-β1) in ectopic endometrium harvested from different groups of mice. The four different columns represent, respectively, ectopic endometrium from mice receiving a mock antibody (NI), platelet depletion antibody (PD), NK cell depletion antibody (ND), and both PD and NK cell depletion antibodies (CD). Magnification in all figures: ×400. The scale bar represents 125 μm. (B) Boxplots of the staining levels of PCNA, VEGF, CD31-labeled MVD and TGF-β1 among the four groups of mice. The p-value of the difference among the four groups is shown in each figure. The statistical significance levels of the difference between the indicated group and the NI group are also shown in the figure in symbols. The dashed line in each figure represents the overall median of all mice. The symbols of statistical significance levels: '*', '**' and '***' indicate that the P-value is <0.05, 0.01, and 0.001, respectively. NS: statistically not significant (P > 0.05), all by Wilcoxon's test.
Co-incubation of endometriotic cells with platelets results in reduced NK cell cytotoxicity
Given the above results, we evaluated the NK cytotoxicity after coincubation of endometriotic cells under different conditions. We found that the co-incubation of HEECs/ESCs with PLT and PLT +THB, but not THB alone, resulted in significantly reduced cytotoxicity in NK cells as compared with those treated with PBS alone (all P-values < 0.01), especially those treated with PLT + THB (all P-values < 0.05; Fig. 4C ). In fact, the cytotoxicity against ESCs/ HEECs incubated with PLT + THB was significantly lower than that of those treated with PLT alone (both P-values < 0.001; Fig. 4C ). Incubation of ESCs/HEECs with either PLT-RLS or PLT-PT also resulted in significantly reduced NK cytotoxicity as compared with those untreated cells (all P-values < 0.01; Fig. 4C ). These results suggest that platelets impair the NK cell cytotoxicity in vitro, likely through reduced NKG2D ligands MICA/B expression in target cells, the pseudoexpression of MHC-I posing as 'pseudo-self,' or because of physical shield provided by activated platelets (Fig. 3A and B) . As expected, NK cytotoxicity was decreased by reduced effector:target cell (E:T) ratio (Fig. 4C ).
Co-incubation of NK cells with platelets impairs NK cytotoxicity
Given impaired NK cell cytotoxicity for endometriotic cells coincubated with platelets, we wondered whether the cytotoxicity also Figure 4 The abundance of major histocompatibility complex class I (MHC-I)-related chain (MICA/B) mRNAs in ESCs (A) and HEECs (B) after coincubation under conditions as indicated. The statistical significance levels for the difference between the co-incubation condition and the controls are indicated by symbols. Natural killer (NK) cell cytotoxicity at different effector-to-target (E:T) ratios (15:1 and 10:1) after ESCs (C) or HEECs (D) were co-incubated with PLT, platelets; PLT+THB, platelets activated by thrombin; THB, thrombin only; PLT-RLS, platelet releasate; PLT-PT, platelet pellets. Symbols of significance levels: *P < 0.05; **P < 0.01; NS: P > 0.05. In both (C) and (D), the comparison was made between the cells co-incubated with phosphate buffer saline (PBS) at the same E:T ratio. In all experiments, n = 8.
is impaired if the effector cells themselves are co-incubated with platelets. To see this, we co-incubated NK cells with PBS, PLT, PLT+THB, PLT-RLS, PLT-PT or THB overnight, and evaluated the NK cytotoxicity against ESCs/HEECs at the E:T ratio = 10:1 and 15:1, respectively. Similarly, we found that the NK cytotoxicity against ESCs/HEECs was significantly reduced after co-incubation of NK cells with PLT, PLT+THB, PLT-RLS, PLT-PT as compared with those treated with either PBS or thrombin (all P-value < 0.05, Fig. 5A ). The percentages of early apoptotic, late apoptotic and viable NK cells after co-incubation with different co-incubation conditions. For all three measurements, the difference between the NK cells in all indicated co-incubation conditions was significantly different (all P-values < 0.05) from those co-incubated with cyclosprin A (as a positive control). Data are presented in mean ± standard deviation. Symbols of significance levels: *P < 0.05; NS: P > 0.05.
Co-incubation with platelets does not induce apoptosis in NK cells
Given impaired NK cytotoxicity after co-incubation of either NK cells with platelets, we asked the question as whether such an impairment was due to the direct effect of platelets on NK cells since activated platelets are reported to exert cytotoxic effect on red blood cells (Okada et al., 1992) . We thus evaluated whether platelets or their releasate or pellet induce apoptosis in NK cells. After NK cells were incubated with PBS, PLT, PLT+THB, PLT-RLS, PLT-PT or THB overnight, we determined the percentages of apoptotic NK cells by FACS. We found that none of these conditions induced NK cell apoptosis, whereas high percentages of apoptotic NK cells were detected in the positive control (Fig. 5B) . Thus, the impaired NK cell cytotoxicity modulated by platelets, their releasate or pellets is not attributable to increased apoptosis in NK cells.
Co-incubation with platelets inhibits NK cell degranulation
Degranulation is the first step toward NK cell killing. We carried out degranulation assays for NK cells that were co-cultured with ESCs/ HEECs and used counterstaining for CD3 and CD56 to see the different cytotoxic lymphocyte subpopulations. The presence of ESCs/ HEECs substantially induced CD107a expression, a marker for granule mobilization on CD3-CD56+NK cells (Fig. 6A) . However, the presence of PLT+THB, PLT-RLS and PLT-PT, but not THB (P > 0.05), significantly reduced the CD107a expression levels (all P-values < 0.05; Fig. 6A ). This indicates that platelets and their releasate and pellets, but not thrombin, inhibited the degranulation of NK cells. . Untreated: NK cells co-cultured in the absence of ESCs/HEECs; PLT, platelets; PLT+THB, platelets activated by thrombin; THB, thrombin only; PLT-RLS, platelet releasate; PLT-PT, platelet pellets. In all experiments, n = 8. *P < 0.05; NS: P > 0.05.
Co-incubation with platelets reduces IFN-γ secretion by NK cells
Since the release of IFN-γ is one of the major mechanisms through which NK cells exert their cytotoxicity, we evaluated whether platelets and their releasate also reduce NK cell IFN-γ production. NK cells were cultured overnight in the presence or absence of platelets, platelet releasate, platelet pellets or their respective controls. The ESCs or HEECs were then added and the culture was carried out for an additional 24 h. While NK cells produced very low levels of IFN-γ in the absence of target cells (Fig. 6B) , the presence of either ESCs or HEECs significantly increased the IFN-γ production by NK cells, which was significantly reduced by the presence of PLT+THB or PLT-RLS (both P-values < 0.05), but not PLT or PLT-PT (both P-values > 0.05, Fig. 6B ). incubated with PLT, platelets; PLT+THB, platelets activated by thrombin; THB, thrombin only; PLT-RLS, platelet releasate; PLT-PT, platelet pellets overnight, and the expression of the select surface receptors were evaluated by real-time RT-PCR (A) and flow cytometry analysis (B, C). In all experiments, n = 8. *P < 0.05; NS: P > 0.05. All comparison was made between the condition of interest and the control group (PBS).
Platelets impair NK cell surface receptor expression
To further understand the molecular mechanisms underlying plateletinduced NK cytotoxicity impairment, we investigated whether preincubation of NK cells with PLT, PLT+THB, PLT-RLS and PLT-PT results in aberrant expression of NK cell surface receptors that have been reported to be involved in endometriosis. NK cells were incubated overnight with PBS, PLT, PLT+THB, PLT-RLS and PLT-PT or THB, and the expression of NK cell receptors, such as NKG2D, NKp44, NKp46, KIR2DL1 and KIR3DL1, was determined by real-time RT-PCR. We found that, compared with NK cells incubated with PBS, the gene expression levels of NKG2D, NKp46 (both NK cell activating receptors) in NK cells were significantly reduced after incubation with PLT+THB, PLT-RLS, and, to a lesser degree, with PLT and PLT-PT (all P-values < 0.05; Fig. 6A ) while that of KIR2DL1 (an inhibitory receptor) were significantly elevated for NK cells incubated with activated platelets and, to a lesser degree, with PLT-RLS and PLT-PT (all P-values < 0.05; Fig. 7A ). No significant difference in expression levels of NKp44 and KIR3DL1 among the different treatment groups was found (all P-values > 0.05; data not shown). Similar results were obtained using FACS analysis. Compared with NK cells incubated with controls, the protein expression levels of both NKG2D and NKp46 in NK cells were significantly reduced while that of KIR2DL1 were significantly elevated after incubation with PLT+THB and, to a lesser degree, also with PLT, PLT-RLS and PLT-PT (all P-values < 0.05; Fig. 7B and C) .
Effect of inhibition of TGF-β1 signaling on NK cell receptors expression
Platelet-derived TGF-β1 reduces the expression of NKG2D in NK cells in PF from endometriosis patients and is responsible, at least in part, for the reduced NK cell cytotoxicity in endometriosis (Okada et al., 1992) . To determine whether the signaling of TGF-β1, which can be released copiously by active platelets (Smyth et al., 2009) and is activated in endometriosis (Komiyama et al., 2007) and high in concentration in serum and PF from women with endometriosis (Pizzo et al., 2002) , is the major culprit responsible for aberrant expression of NKG2D, NKp46 and KIR2DL1 in NK cells after incubation with activated platelets and PLT-RLS, we further evaluated the expression of these receptors after pre-treatment with A83-01, an inhibitor of TGF-β Type I receptor. We found that the inhibition of TGF-β1 signaling with A83-01 significantly attenuated the reduction in gene expression of NKG2D and of NKp46 in NK cells co-incubated with PLT-RLS and PLT+THB, and also significantly abrogated the increase in KIR2DL1 expression when co-incubated with PLT-RLS (all P-values < 0.05; Fig. 8A ). While NK cell KIR2DL1 expression was significantly elevated after co-incubation with activated platelets and TGF-β1 neutralization attenuated the increase in gene expression, the reduction did not reach statistical significance (P > 0.05; Fig. 8A ). These data indicate that platelet-derived TGF-β1 is responsible for reduced NKG2D and NKp46 expression and increased KIR2DL1 expression in NK cells. As expected, the inhibition of TGF-β1 signaling partially restored the impairment of NK cell cytotoxicity induced by activated platelets and their releasate (all P-values < 0.05; Fig. 8B ).
Discussion
In this study, we have provided firstly in vivo evidence that antiendometriosis effect of PD is mediated, at least in part, by increased NK cell cytotoxicity against endometriotic cells. We also have shown that platelet coating provides target cells a physical shield against NK cells as well as increased MHC-I expression, effectively providing a cloak of 'pseudo-self' to target cells to shield against NK cell lysis. Coincubation of target cells with platelets reduces the expression of NKG2D ligands MICA and MICB and reduces the NK cell cytotoxicity. In addition, co-incubation of NK cells with platelets also impairs the NK cell cytotoxicity. This impaired NK cell cytotoxicity is not due to the increased NK cell apoptosis, but, rather, through reduced NK cell degranulation and IFN-γ production, and reduced expression of activating receptors NKG2D and NKp46 and increased expression of inhibitory receptor KIR2DL1 in NK cells. TGF-β1 neutralization abolishes the aberrant expression of NKG2D, NKp46 and KIR2DL1, and partially restores the impaired NK cell cytotoxicity induced by activated platelets and their releasate. Taken together, these data provide a strong piece of evidence that platelets impair NK cell cytotoxicity in endometriosis through multiple mechanisms and both soluble and membrane-bound factors are required for NK cell evasion of endometriotic cells.
Our data are consistent with the previous report that plateletderived soluble factors do not induce NK cell death (Kopp et al., 2009) . They are also consistent with our previous report that plateletderived TGF-β1 suppresses the expression of NKG2D on NK cells, resulting in reduced cytotoxicity in women with endometriosis, but inhibition of TGF-β1 signaling reverses the reduction (Guo et al., 2016c) .
Our study demonstrates that depletion of NK cells and platelets resulted in an average of 67% increase and 68% decrease in lesion weight, respectively, in a mouse model of endometriosis. In addition, concomitant depletion of NK cells and platelets also resulted in an average of 69% increase in lesion weight. Thus, it highlights the point that NK cells provide an effective impedance to the development of endometriosis, but platelets protect endometriotic cells from NKmediated immunosurveillance and removal. This is very similar to the case of cancer cells (Nieswandt et al., 1999) .
Our data provide evidence that this platelet-mediated impairment of NK cell activity is through multiple mechanisms, i.e. reduced expression of NKG2D ligands MICA/B, reduced NK cell degranulation and IFN-γ production, the provision of a physical cloak, thus yielding a steric hindrance of the interaction between NK cells and endometriotic cells, and, more importantly, through modulation of the NK cell surface receptors and hence interfering with the identification and lysis of endometriotic cells by NK cells. By physically cloaking endometriotic cells, platelets may transfer MHC-I antigen to the cells, effectively conferring an immune phenotype of 'pseudo self' or decoy to endometriotic cells. In this way, endometriotic cells evade 'missing self' recognition, undermining the NK cell immunosurveillance. Our data provide evidence that platelets expressing MHC-I coat target cells and induce enhanced MHC-I expression in target cells, effectively providing a decoy cover that allows immuneescaping. Alternatively, platelets may transfer immunosuppressive proteins to endometriotic cells as in cancer cells (Placke et al., 2012a,b,c) . Termed as trogocytosis (Joly and Hudrisier, 2003) , such a transfer of immunoregulatory molecules between lymphocytes with other cells has previously been documented (Millet et al., 2008; Qu et al., 2009) .
Our data also provide evidence that the impaired NK cell cytotoxicity in endometriosis is also attributable to platelet-derived TGF-β1, which is released copiously upon activation (Smyth et al., 2009) . TGF-β1 downregulates the activating NK receptor NKG2D as shown here and also reported previously (Guo et al., 2016c) as well as NKp46, which was reported to be down-regulated in endometriosis (Funamizu et al., 2014) . It also up-regulates KIR2DL1 but not KIR3DL1 (Wu et al., 2000) or NKG2A (Galandrini et al., 2008) , again as we found also. Hence, platelets and their interaction with both NK cells and endometriotic cells can explain several aberrations in NK cell activity that have been reported, namely, the increased expression of KIR2DL1 (Maeda et al., 2002 (Maeda et al., , 2004 Matsuoka et al., 2005) and reduced expression of NKp46 (Funamizu et al., 2014) and of NKG2D (Guo et al., 2016c) . In addition, Figure 9 Schematic illustration of multiple mechanisms underlying platelet-impaired NK cell function and cytotoxicity in endometriosis. Platelet coating provides endometriotic cells a physical shield against NK cells as well as increased MHC-I expression, effectively providing a cloak of 'pseudo-self' to endometriotic cells to protect against NK cell lysis. Activated platelets or their secreted soluble factors such as TGF-β1 induce the expression of NKG2D ligands MICA and MICB and reduce the NK cell cytotoxicity. Platelets and their secreted soluble factors such as TGF-β1 can also have direct effect on NK cells, impairing the cytotoxicity. This impaired NK cell cytotoxicity is not due to the increased NK cell apoptosis, but, rather, through reduced NK cell degranulation and IFN-γ production, and reduced expression of activating receptors such as NKG2D and NKp46 and increased expression of inhibitory receptor KIR2DL1 in NK cells.
both platelet-derived and endometriosis-derived TGF-β1 due to TGF-β1/Smad3 activation by platelets (Zhang et al., 2016) can exert negatively on NK cell function and should be responsible for reported reduced NK cell cytotoxicity resulting from exposure to PF (Oosterlynck et al., 1993) and sera (Kanzaki et al., 1992) from patients with endometriosis as well as endometriosis-secreted factors (Hirata et al., 1994; Somigliana et al., 1996a,b) . Of course, endometriosis-derived ICAM-1 (Vigano et al., 2001) or IL-15 (Yu et al., 2016) might also influence NK cell reactivity in endometriosis. We summarize our findings in a schematic diagram depicting platelet-mediated impairment of NK cell activity in endometriosis (Fig. 9) .
Once again, this study underscores the importance of platelets in the pathophysiology of endometriosis. Platelets and endometriotic cells constantly engage cross-talk, ultimately resulting in fibrosis Guo et al., 2015; Zhang et al., 2015; Guo et al., 2016a ,b,c, Zhang et al., 2016a . While endometriosis is widely viewed as an hormonal disease (Bulun et al., 2005) and an inflammatory condition (Burney and Giudice), emerging data indicate that endometriosis also is a hypercoagulable condition (Wu et al., 2015; Munros et al., 2016) . As shown previously (Guo et al., 2016c) and in this study, platelets also are responsible for impaired NK cell cytotoxicity in endometriosis. Apart from these, other immunoregulatory molecules known to be expressed on platelets upon activation may also impact negatively on NK cell function and/or reactivity. For example, glucocorticoid-induced TNF-related ligand (GITRL) is expressed by platelets upon platelet activation. Like MHC-I, GITRL might also be rapidly mobilized to the platelet surface and transferred to endometriotic cells as in tumor cells, resulting in reduced NK cell cytotoxicity (Placke et al., 2012a,b,c) . In addition, NK cells co-incubated with platelet ectosomes, i.e. vesicles budding from platelet surface, results in reduced expression of several activating surface receptors (NKG2D, NKp30 and DNAM-1) and decreased NK cell function, as measured by CD107a expression and IFN-γ production (Sadallah et al., 2016) . Consequently, anti-platelet therapy may hold promises for treating endometriosis as shown in animal models .
Our finding that the co-incubation of target cells with platelets reduces the expression of NKG2D ligands MICA and MICB may appear to be at odds with a recent report that the concentrations of soluble NKG2DLs MICA/B, and ULBP-2 are elevated in the PF of women with deep infiltrating endometriosis (Gonzalez-Foruria et al., 2015) . Difference in materials aside (ESCs or endometriotic epithelial cells versus PF harvested from women with deep infiltrating endometriosis), we point out that the shed soluble MICA/B (sMICA/B) may actually reduce the expression of the ligands on target cells and cause the degradation of NKG2D on NK cells, resulting in suppression of NK cell function (Groh et al., 2002) . Alternatively, prolonged chronic exposure of NKG2DLs may render NK cells desensitized (Pradeu et al., 2013) , again yielding suppressed NK cell function.
While we believe that NK cell functions and cytotoxicity are impaired in women with endometriosis just as the way as we depicted here, caution should be exercised due to several limitations in this study. First, most data that we presented are in vitro in nature. Due to ethical constraints, the best in vivo data we had are from mouse experimentation, in which the disease may not completely recapitulate its human counterpart. Hence more direct evidence from humans would be highly desirable. Second, we used an endometriotic epithelial cell line and an ESC line as target cells, both of which may not behave exactly the same way as the primary endometriotic epithelial and stromal cells. Future studies using primary endometriotic epithelial and stromal cells, preferably from women with endometriosis of different stages, as target cells may be desirable. In addition, the use of platelets and NK cells derived from the same women would also be ideal. However, since currently the most widely used staging system, i.e. rASRM classification, only measures the extensiveness of endometriosis and is by no means synonymous with the stages of the endometriosis development, extra care needs to be taken to determine as what constitutes the 'stage' of endometriosis. Furthermore, as implicated in our data, the NK cells in women with endometriosis may already have impaired functionality and/or cytotoxicity due to the hypercoagulable state in women with endometriosis (Wu et al., 2015; Munros et al., 2016) , as shown in our study. Even platelets in women with endometriosis might also be hyper-reactive or have an aberrant lipid profile, for which little data are available as of now. This reveals just how little we know about the roles of coagulation signaling pathways in endometriosis and also highlights the challenges we face in disentangling the relationship between platelets and NK cells in the development of endometriosis. Further research is warranted to elucidate these issues.
In summary, this study not only elucidates mechanisms by which endometriotic lesions interact with platelets to impair NK cell function and activity to evade cell immunosurveillance but also demonstrate that platelets, as a newly indicted culprit in the development of endometriosis, are an important player in this estrogen-dependent inflammatory disease and, as such, should be taken into account in strategies when devising interventional measures.
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